New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered
Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration. Shipments of the medication are expected to go out in just a couple of weeks. Hospitals are on tap to administer treatment when needed. And there is serious division in the FDA,
Continue Reading